Form 4: Genpact Director Nicholas C. Gangestad Acquires 2,000 Common Shares
SEC Form 4
Director Nicholas C. Gangestad reports the acquisition of 2,000 common shares of Genpact LTD on May 13, 2025.
Summary
- On May 13, 2025, Nicholas C. Gangestad, a director of Genpact LTD, acquired 2,000 common shares of the company.
- The shares were purchased at a price of $43.97 per share.
- Following the transaction, Mr. Gangestad directly owns 2,000 common shares of Genpact LTD.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction report. The director's purchase is a slightly positive signal, but the overall impact is likely minimal.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of regulatory compliance for company insiders and provide transparency into their trading activities. This purchase is a small transaction and may not have a significant impact on the overall market sentiment towards Genpact.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment due to the director's increased investment in the company.
Key Dates
| Date | Description |
|---|---|
| 05/13/2025 | Date of transaction: Nicholas C. Gangestad acquired 2,000 common shares. |
| 05/14/2025 | Date of signature: Form 4 signed by Thomas D. Scholtes, as Attorney-in-fact for Nicholas C. Gangestad. |
Keywords
Genpact, Director, Share Acquisition, Form 4, Nicholas C. Gangestad, Common Shares
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.